The Beauty Health Company (NASDAQ:SKIN) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ET

Company Participants

Eduardo Rodriguez - Senior Director, M&A and Investor Relations

Andrew Stanleick - President, Chief Executive Officer & Director

Liyuan Woo - Chief Financial Officer

Brad Hauser - Chief Operating Officer

Michael Monahan - Incoming Chief Financial Officer

Conference Call Participants

Oliver Chen - TD Cowen

Korinne Wolfmeyer - Piper Sandler & Co.

Margaret Kaczor - William Blair

Jon Block - Stifel, Nicolaus & Company

Navann Ty - BNP Paribas Exane

Olivia Tong - Raymond James

Allen Gong - JPMorgan

Linda Bolton-Weiser - D.A. Davidson & Co.

Bruce Jackson - The Benchmark Company

Operator

Good day and welcome to The Beauty Health Company Second Quarter 2023 Earnings Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Eduardo Rodriguez, Senior Director of M&A and Investor Relations. Please go ahead.

Eduardo Rodriguez

Thank you, operator and good morning, everyone. Thank you for joining The Beauty Health Company's conference call to discuss our second quarter 2023 financial results, which were released this morning and can be found on our website at beautyhealth.com. We encourage you to join the webcast accessible on our website, which contains a presentation that will be referenced during this call.

With me today are Beauty Health's President and Chief Executive Officer, Andrew Stanleick; Incoming Chief Financial Officer, Michael Monahan and Chief Operating Officer, Brad Hauser

Before we begin, I would like to remind you of the company's safe harbor language. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. Listeners are cautioned not to place undue reliance on any forward-looking statements. For a further discussion of risks related to our business, see our filings with the SEC. This call will present non-GAAP financial measures. Reconciliation of these non-GAAP measures to the most comparable GAAP measures are in the earnings release furnished to the SEC and available on our website.

I will now turn the call over to Andrew.

Eduardo Rodriguez

Thank you, Eduardo, and thank you, everyone, for joining us. Today's call is going to be organized a bit different than usual. First, we'll review the highlights of our Q2 results before turning to some key learnings and actions taken through this period of rapid growth. I will then walk you through our 2023 outlook, and we will conclude with a preview of our innovation pipeline from Chief Operating Officer, Brad Hauser.